Whole brain radiation dose reduction for primary central nervous system lymphoma patients who achieved partial response after high-dose methotrexate based chemotherapy

Author:

Park Jun Su1,Lim Do Hoon1,Ahn Yong Chan1,Park Won1,Kim Seok Jin2,Kim Won Seog2,Kim Kihyun2

Affiliation:

1. Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine

2. Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Reference22 articles.

1. Radiation therapy in the management of primary malignant lymphoma of the brain;Berry;Int J Radiat Oncol Biol Phys,1981

2. Non-Hodgkin’s lymphoma of the brain: can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation Therapy Oncology Group (RTOG): RTOG 8315;Nelson;Int J Radiat Oncol Biol Phys,1992

3. Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 93-10;DeAngelis;J Clin Oncol,2002

4. Long-term survival in primary CNS lymphoma;Abrey;J Clin Oncol,1998

5. Delayed neurotoxicity in primary central nervous system lymphoma;Omuro;Arch Neurol,2005

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3